Publication:
Chlorpromazine Intoxication With Related Hyperamylasemia

Simple item page
dc.authorwosidTulek, Necla/M-3283-2017
dc.authorwosidBaydin, Ahmet/Aag-4188-2019
dc.contributor.authorGenc, S.
dc.contributor.authorAyguen, D.
dc.contributor.authorKaratas, A. D.
dc.contributor.authorTuelek, N.
dc.contributor.authorBaydin, A.
dc.contributor.authorDervisoglu, A.
dc.date.accessioned2025-12-11T00:42:33Z
dc.date.issued2008
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Genc, S.; Ayguen, D.; Karatas, A. D.; Baydin, A.; Dervisoglu, A.] Ondokuz MayIs Univ, TIp Fak Acil TIp AD 1, TR-55139/ Samsun, Turkey; [Tuelek, N.] Ondokuz MayIs Univ, TiP Fak Enfeksiyon HastalIklarI 2, Samsun, Turkeyen_US
dc.description.abstractChlorpromazine is an antipsychotic drug with low potency involved in phenothiazine group. In mild intoxication, sedation, ataxia, blurry vision; in moderate and severe intoxication coma and anticholinergic side effects can be seen. In literature according to our researches, there's limited data that hyperamylasemia is asosiated with chlorpromazine intoxication. We presented a case with hyperamylasemia that we thought that it was due to chlorpromazine intoxication.en_US
dc.description.woscitationindexEmerging Sources Citation Index
dc.identifier.endpage37en_US
dc.identifier.issn2149-5807
dc.identifier.issn2149-6048
dc.identifier.issue2en_US
dc.identifier.startpage36en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/38637
dc.identifier.volume7en_US
dc.identifier.wosWOS:000420085600007
dc.language.isotren_US
dc.publisherAvesen_US
dc.relation.ispartofEurasian Journal of Emergency Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChlorpromazine Intoxicationen_US
dc.subjectHyperamylasemiaen_US
dc.titleChlorpromazine Intoxication With Related Hyperamylasemiaen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu